News & Events

Pharmacogenomics company OneOme moves steps closer to product launch

Minneapolis company announces new chief executive, headquarters and lab

Minneapolis, Minn., July 12, 2016 – In preparation for its full launch of the RightMed® pharmacogenomic test, OneOme announces Paul Owen as Chief Executive Officer and opens its new headquarters and lab in northeast Minneapolis. By mid-July, OneOme will make the RightMed test commercially availab...


Pharmacogenomics company OneOme achieves more key milestones

Minneapolis company announces new leadership and first exhibition

Minneapolis, Minn., June 20, 2016 – Pharmacogenomics company OneOme is pleased to announce key business milestones in advance of launching its RightMed test.

The RightMed test is a cost-effective, comprehensive, personalized pharmacogenomic analysis of 22 genes provided at the point of care. The t...


OneOme expands leadership team in preparation for mid-year launch of its comprehensive pharmacogenomic test

MINNEAPOLIS, March 17, 2016 /PRNewswire/ — OneOme, LLC, a pharmacogenomics company, announced today the hiring of Dr. Justin Odegaard, M.D., Ph.D. and Ross Higgins to manage and lead their pharmacogenomics testing laboratory. Both Dr. Odegaard and Mr. Higgins bring extensive background in laborato...


Wall Street Journal: Is your medicine right for your metabolism?

The Wall Street Journal published an article explaining the benefits of pharmacogenomic testing. Pharmacogenomics identifies which inherited genetic variations a person has and predicts how an individual will — or will not — respond to specific medications.

Because everyone responds to drugs di...


OneOme prepares for commercial launch in new state-of-the-art facility

MINNEAPOLIS, Minnesota—OneOme, LLC, a pharmacogenomics company, announced today that it will move its corporate office and clinical laboratory to the Highlight Center in northeast Minneapolis in early 2016. The new location will expand OneOme’s operations with a high-throughput clinical laborato...